GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerations

MJ Jespersen, FK Knop… - Expert opinion on drug …, 2013 - Taylor & Francis
Introduction: Within recent years, glucagon-like peptide 1 receptor agonists (GLP-1-RA)
have emerged as a new treatment option for type 2 diabetes. The GLP-1-RA are …
被引用次数：56 相关文章

GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerations: pharmacokinetic and toxicological considerations

MJ Jespersen, FK Knop… - Expert Opinion on Drug …, 2013 - research.regionh.dk
Within recent years, glucagon-like peptide 1 receptor agonists (GLP-1-RA) have emerged as
a new treatment option for type 2 diabetes. The GLP-1-RA are administered subcutaneously …

GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerations.

MJ Jespersen, FK Knop… - Expert Opinion on Drug …, 2012 - europepmc.org
GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerations. - Abstract
- Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …

GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerations

MJ Jespersen, FK Knop… - Expert opinion on drug …, 2013 - pubmed.ncbi.nlm.nih.gov
Introduction Within recent years, glucagon-like peptide 1 receptor agonists (GLP-1-RA) have
emerged as a new treatment option for type 2 diabetes. The GLP-1-RA are administered …